| March 13, 2025 |
- The company’s 2024 business report and financial statements (IFRSs).
- The 2024 employees’ and directors’ compensation.
- The 2024 earnings distribution.
- The assessment of the competence and independence of the certifying CPA and the review of audit fees.
- The follow-up on the financial reporting capability improvement plan.
- The assessment of the effectiveness of the company’s internal control system for 2024 and the internal control system statement.
- The proposal on defining the scope of entry-level employees.
- The amendments to the “Internal Controls” and the “Internal Audit”.
- The amendments to certain provisions of the company’s articles of incorporation.
- The sale of equipment by the company to its subsidiary, Song Chuan (Xiamen) (for business use).
- The proposal to enter into the over-allotment and specific shareholders’ lock-up agreement with Yuanta.
- The lifting of non-competition restrictions for directors.
- Matters relating to the convening of the 2025 annual general meeting of shareholders.
- Matters relating to the acceptance of shareholder proposals for the 2025 annual general meeting of shareholders.
|
Approved unanimously by all attending directors without objection. |
| March 28, 2025 |
- The proposal for the company to extend loans to its subsidiaries.
|
Approved unanimously by all attending directors without objection. |
| April 18, 2025 |
- The assessment of the effectiveness of the company’s internal control system for the period from April 1, 2024 to March 31, 2025 and the internal control system statement.
- The company’s financial forecasts for the second and third quarters of 2025.
- The company’s “Corporate Governance Evaluation Self-Assessment Report.”
- The establishment of the company’s “Risk Management Best-Practice Principles” and “Risk Management Policies and Procedures.”
- The appointment of the company’s chief information security officer and information security personnel.
- Approval of the appointment of the company’s acting spokesperson.
|
Approved unanimously by all attending directors without objection. |
| May 12, 2025 |
- The company’s first quarter 2025 financial statements (IFRSs).
- The company’s financial forecasts for the second and third quarters of 2025.
|
Approved unanimously by all attending directors without objection. |
| May 29, 2025 |
- Ratification of the acquisition of Shanghai Song Chuan Precision Electron Co., Ltd., as approved by the board of directors on April 15, 2022.
- Ratification of the purchase of production equipment by the subsidiary, Song Chuan (Xiamen) Precision Electron Co., Ltd., from Xiamen Song Chung Precision Co., Ltd., as approved by the board of directors on October 27, 2023.
- Approval of the cash capital increase for the subsidiaries, Song Chuan (Xiamen) and Song Chuan Precision Europe GmbH.
|
Approved unanimously by all attending directors without objection. |
| July 21, 2025 |
- The proposal on the number of shares to be issued, the tentative price range, the purpose and the expected benefits of the company’s pre-IPO cash capital increase.
- The allocation of subscription quotas reserved for non-managerial officers in connection with the company’s pre-IPO cash capital increase issuance of new shares.
- The allocation of subscription quotas reserved for managerial officers in connection with the company’s pre-IPO cash capital increase issuance of new shares.
- The company’s application for bank credit lines to meet operating funding needs.
- The provision of endorsements and guarantees by the company for its subsidiary.
- The sale of equipment by the company to its subsidiary, Song Chuan (Xiamen) (for business use).
|
Approved unanimously by all attending directors without objection. |
| August 13, 2025 |
- The company’s second quarter 2025 financial statements (IFRSs).
- The amendments to the company’s “Rules of Procedure for Board of Directors Meetings,” “Internal Controls,” and “Internal Audit.”
- The preparation of the company’s sustainability report.
- The sale of equipment by the company to its subsidiary, Song Chuan (Xiamen) (for business use).
|
Approved unanimously by all attending directors without objection. |
| November 13, 2025 |
- The company’s third quarter 2025 financial statements (IFRSs).
- The amendments to the general principles of the pre-approval of non-assurance services policy(general policy).
- The amendments to the company’s “Sustainable Development Best Practice Principles,” “Corporate Governance Best Practice Principles,” “Procedures for Handling Material Inside Information and Filing Insiders’ New Appointment (Dismissal) Information,” and “Procedures for Applying for the Halt and Resumption of Emerging Stock TPEx Trading.”
- The amendments to the company’s “Internal Controls” and “Internal Audit.”
- The changes to the company’s information security personnel.
- The sale of equipment by the company to its subsidiary, Song Chuan (Xiamen) (for business use).
- The appointment of the company’s general manager.
|
Approved unanimously by all attending directors without objection. |
| December 22, 2025 |
- The assessment of the competence and independence of the certifying CPA and the review of audit fees.
- Approval of the 2026 annual audit plans.
- Approval of the 2026 business plans (including budget).
- The provision of endorsements and guarantees by the company for its subsidiary.
- The amendments to the “Approval Authorization Matrix.”
- The appointment and compensation of the chief strategy officer.
- The individual compensation and amount for the company’s managerial officers.
- The annual remuneration for the company’s managerial officers.
- The dismissal of the company’s managerial officers.
- The sale of equipment by the company to its subsidiary, Song Chuan (Xiamen) (for business use).
|
Approved unanimously by all attending directors without objection. |
